The Perfect Weight Loss Companion Enhance your daily diet with essential support to mitigate side effects, enhance body composition and overall health, potentially paving the way for a healthy transition away from your weight loss medication
The GLP-1 compounding market changed significantly in 2025-2026 under FDA enforcement
This explosive demand is projected to propel the global GLP-1 analogues market from $54.8 billion in 2024 to a staggering $268.4 billion by 2030 , reflecting a remarkable Compound Annual Growth Rate (CAGR) of 30.6% from 2025 to 2030
The impact of exenatide on cognitive function in patients with raised ICP has not been explored
While the SAFE Drugs Act remains under legislative consideration, the FDA and state attorneys general appear to already be implementing more aggressive oversight measures until a more stringent oversight framework is in place
At the State Level: The real momentum for reform has been at the state level, with 2025 being dubbed the year of PBM reform